Crimeans told about the prospects for the use of oncological vaccine

The oncological vaccine remains a promising direction in the treatment of cancer, but is not yet ready to become a universal remedy. This was stated by an oncologist, candidate of medical Sciences Evgeny Cheremushkin, writes NEWS.ru.

According to Evgeny Cheremushkin, the oncological vaccine is an advanced technique in the fight against cancer. The immune system controls the process of cell division, so the use of immunotherapy components is considered one of the most anticipated areas in oncology.

The specialist confirmed that the first patient who received the oncological vaccine disappeared metastases. This case, he said, indicates the right direction of work. However, a single success does not yet indicate a complete trend.

“Sometimes we get an effect once and then we get five without it. We'll just wait. We will be glad when the control group of patients has already been thoroughly recruited, Cheremushkin said.

The doctor stressed that in order to introduce the technology into broad medical practice, it is necessary to conduct additional research and work out the methodology.

Recall that in the Crimea, development in the field of antitumor vaccines has been conducted since the early 2020s. In February 2022, Vice-Rector of Vernadsky KFU for Scientific Activities, Doctor of Medical Sciences Anatoly Kubushkin reported that a cell vaccine against cancer was being developed at the university.

Its essence is to “train” immune cells to recognize the tumor antigen, find it and destroy it. Studies have already been started, however, according to Kubushkin, the work was long, and the timing of its completion was not called.

In March 2022, it became known about another project - a unique biomedical technology for immunotherapy of cancers of a wide range. Igor Samokhvalov, Head of the Department of Biomedical Technologies of the Engineering Center "Genetic and Cell Biotechnology" of KFU, said that the regenerative medicine approach will be used to stimulate the immunity of cancer patients.

Crimean scientists have developed a method for obtaining a large number of “trained” immune cells from human pluripotent stem cells. For the implementation of the project, the university won a grant from the Russian Science Foundation in the amount of 19 million rubles, designed for three years.